Skip to Main Content

Paper Details

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
Health Technol Assess
3
2021
Bisphosphonate, Bisphosphonates, PARTICIPANTS, Patients, acute kidney injury, bisphosphonate, bisphosphonates, bone fractures, chronic kidney disease, fragility fractures, hip fracture, hip fractures, hypocalcaemia, hypophosphataemia, osteoporosis, participants, patients, upper gastrointestinal events
Author NameAffiliation
Yoav Ben-ShlomoUniversity of Bristol
Cyrus CooperNational Institute for Health Research (NIHR) Biomedical Research Centre, University of Oxford
Cyrus CooperMedical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital
Antonella DelmestriNational Institute for Health Research (NIHR) Biomedical Research Centre, University of Oxford
Daniel Prieto-AlhambraNational Institute for Health Research (NIHR) Biomedical Research Centre, University of Oxford
Daniel Prieto-AlhambraUniversity Institute for Primary Care Research (IDIAP) Jordi Gol, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III
Daniel Prieto-AlhambraNational Institute for Health Research (NIHR) Biomedical Research Centre, University of Oxford
Daniel Prieto-AlhambraUniversity Institute for Primary Care Research (IDIAP) Jordi Gol, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III
  • 1 - 8

Datasets

Release 1.2